1 |
Amaravadi R (2009). Autophagy can contribute to cell death when combining targeted therapy. Cancer Biol Ther, 8, 130-3.
|
2 |
Behrends C, Sowa ME, Gygi SP, Harper JW (2010). Network organization of the human autophagy system. Nature, 466, 68-76.
DOI
|
3 |
Bensaad K, Cheung EC, Vousden KH (2009). Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J, 28, 3015-26.
DOI
|
4 |
Bhatnagar A, Liu SQ, Ueno N, et al (1994). Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding. Biochim Biophys Acta, 1205, 207-14.
DOI
|
5 |
Chen Y, Klionsky DJ (2011). The regulation of autophagy: unanswered questions. J Cell Sci, 124, 161-70.
DOI
|
6 |
Cho DH, Jo YK, Kim SC, Park IJ, Kim JC (2012). Down-regulated expression of ATG5 in colorectal cancer. Anticancer Res, 32, 4091-6.
|
7 |
de Duve C (1963). The lysosome. Sci Am, 208, 64-72.
|
8 |
de Duve C, Wattiaux R (1966). Functions of lysosomes. Annu Rev Physiol, 28, 435-92.
DOI
|
9 |
Dengjel J, Kristensen AR, Andersen JS (2008). Ordered bulk degradation via autophagy. Autophagy, 4, 1057-9.
DOI
|
10 |
Desai MD, Saroya BS, Lockhart AC (2013). Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers. Expert Opin Investig Drugs, 22, 341-56.
DOI
|
11 |
Du P, Cao H, Wu HR, et al (2013). Blocking Bcl-2 leads to autophagy activation and cell death of the HEPG2 liver cancer cell line. Asian Pac J Cancer Prev, 14, 5849-54.
DOI
ScienceOn
|
12 |
Fels DR, Ye J, Segan AT, et al (2008). Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res, 15, 9323-30.
|
13 |
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008, GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
DOI
|
14 |
Groulx JF, Khalfaoui T, Benoit YD, et al (2012). Autophagy in normal mucosa. Autophagy, 8, 893-902.
DOI
|
15 |
Guo GF, Jiang WQ, Zhang B, et al (2011). Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol, 17, 4779-86.
DOI
|
16 |
Han Y, Xue XF, Shen HG, Guo XB, Wang X, et al (2014). Prognostic significance of Beclin-1 expression in colorectal cancer: a meta-analysis. Asian Pac J Cancer Prev, 15, 4583-7.
DOI
|
17 |
Kabeya Y, Mizushima N, Yamamoto A, et al (2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci, 117, 2805-12.
DOI
ScienceOn
|
18 |
Koukourakis MI, Giatromanolaki A, Sivridis E, et al (2010). Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer, 103, 1209-14.
DOI
|
19 |
Kreuzaler P, Watson CJ (2012). Killing a cancer: what are the alternatives? Nat Rev Cancer, 12, 411-24.
DOI
|
20 |
Lee J, Giordano S, Zhang J (2012). Autophagy, mitochondria and oxidative stress: cross-talk and redox signaling. Biochem J, 441, 523-40.
DOI
|
21 |
Liu EY, Ryan KM (2012). Autophagy and cancer - issues we need to digest. J Cell Sci, 125, 2349-58.
DOI
|
22 |
Pandey S, Chandravati (2012). Autophagy in cervical cancer: an emerging therapeutic target. Asian Pac J Cancer Prev, 13, 4867-71.
DOI
ScienceOn
|
23 |
Pandey S, Srivastava SK, Ramana KV (2012). A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases. Expert Opin Investig Drugs, 21, 329-39.
DOI
|
24 |
Sato K, Tsuchihara K, Fujii S, Sugiyama M, et al (2007). Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res, 67, 9677-84.
DOI
|
25 |
Shi Y, Tang B, Yu PW, et al (2012). Autophagy Protects against Oxaliplatin-Induced Cell Death via ER Stress and ROS in Caco-2 Cells. PLoS One, 7, 51076.
DOI
|
26 |
Shoji-Kawata S, Sumpter R, Leveno M, et al (2013). Identification of a candidate therapeutic autophagy-inducing peptide. Nature, 494, 201-6.
DOI
|
27 |
Srivastava S, Chandra A, Bhatnagar A, et al (1995). Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem Biophys Res Commun, 217, 741-6.
DOI
|
28 |
Srivastava S, Dixit BL, Cai J, et al (2000). Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase. Free Radic Biol Med, 29, 642-51.
DOI
|
29 |
Tanida I, Ueno T, Kominami E (2004). LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol, 36, 2503-18.
DOI
|
30 |
Tengku Din TA, Seeni A, Khairi WN, Shamsuddin S, Jaafar H (2014). Effects of rapamycin on cell apoptosis in MCF-7 human breast cancer cells. Asian Pac J Cancer Prev, 15, 10659-63.
|
31 |
Vander Jagt DL, Kolb NS, Vander Jagt TJ, et al (1995). Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta, 1249, 117-26
DOI
|
32 |
Wang ZH, Xu L, Wang Y, et al (2011). Clinicopathologic correlations between human papillomavirus 16 infection and Beclin 1 expression in human cervical cancer. Int J Gynecol Pathol, 30, 400-6.
DOI
|
33 |
Wu WK, Wu YC, Yu L, et al (2008). Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Biophys Res Commun, 374, 258-63.
DOI
|
34 |
Yang WL, Perillo W, Liou D, Marambaud P, Wang P (2012). AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells. J Surg Oncol, 106, 680-8.
DOI
ScienceOn
|
35 |
Yang ZJ, Chee CE, Huang S, Sinicrope FA (2011). The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther, 10, 1533-41.
DOI
|
36 |
Zhang YH, Wu YL, Tashiro S, Onodera S, Ikejima T (2011). Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol Sin, 32, 1266-75.
DOI
|